May 17, 2013
$PVCT CEO Letter: PV-10 may cure multiple cancer indications
One of the letter's most key sentences is found in the opening paragraph: "The progress we have made on all fronts confirms our underlying belief in the value of our products and their potential to create a new paradigm for cancer treatment as well as value for our shareholders." Of this sentence, the key phrase is: "a new paradigm for cancer treatment." Craig has innovated a very unique small molecule oncology compound that appears very capable of successfully treating many different cancers. Third party Moffitt has covered multiple indications (e.g., melanoma, breast, lung).